RxDoctor Payments Data

Walter Setlock, DO

Family Medicine · Frackville, PANPI 1881668473

Payments from drug & device makers

$655in general payments, 2019–2025

Across 50 payments — averaging $13.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$156
  • Lilly USA, LLC$75
  • Inspire Medical Systems, Inc.$74
  • AstraZeneca$55
  • Merck$48
  • Novo Nordisk$43
  • plus $205 from 10 others

What the payments were for

  • Food & beverage$655100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$655 in reported general payments places this provider in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$128,974
Medicare patients
391
Services billed
1,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban176$176,031
JanuviaSitagliptin Phosphate110$108,791
OzempicSemaglutide82$94,129
XareltoRivaroxaban76$69,111
JardianceEmpagliflozin56$59,785
MounjaroTirzepatide34$45,155
TradjentaLinagliptin39$26,954
FarxigaDapagliflozin Propanediol28$23,040
TrulicityDulaglutide14$13,049
Spiriva RespimatTiotropium Bromide14$12,806
Fluticasone-SalmeterolFluticasone Propion/Salmeterol32$8,803
Breo ElliptaFluticasone/Vilanterol17$8,440
Rosuvastatin Calcium391$7,455
Atorvastatin Calcium490$7,009
Metoprolol Succinate372$6,761

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$156$176,031176 claims
MerckJanuvia$48$108,791110 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$39$99,545109 claims
Novo NordiskOzempic$43$94,12982 claims
Lilly USA, LLCMounjaro, Trulicity$75$58,20448 claims
AstraZenecaFarxiga$55$23,04028 claims
GSKBreo Ellipta, Arnuity Ellipta$28$14,90928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Frackville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →